Delivery Order SPE2DR25D3020-SPE2DR26F9S2P
Award Date 2/23/26
Potential Completion Date 3/16/26
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for Ibrance 125 mg capsule 21-count units, with a ceiling value of $8,555.21. Place of performance is Conshohocken, PA. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. Ultimate completion date is March 13, 2026. Pricing is firm fixed price under a non-set-aside competitive...
- The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of Ibrance 125 mg tablets (7s). This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2026. The contract provides pharmaceutical and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 18, 2026, with a ceiling value of $34,239.36 for supply of Ibrance 100 mg capsules (21-count packaging). Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 11, 2026. Pricing is firm fixed price. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, with a ceiling value of $8,561.41 for supply of Ibrance 75 mg tablets (7 tablets).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 13, 2026. The order is firm fixed price and was awarded without set-aside under the DLA Troop Support Medical Indefinite Delivery Contract.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for IBRANCE 75 MG Tablet 7S with a ceiling value of $8,561.41.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. Pricing is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Ibrance 100 mg tablets (7-count) with a ceiling value of $8,559.84.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion by March 2, 2026. Pricing is firm fixed price. No set-aside was used.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for Ibrance 125 mg capsules (21-count), with a ceiling value of $8,555.21 under a firm fixed-price arrangement. Place of performance is Conshohocken, PA. Ultimate completion date is February 24, 2026. The order carries no set-aside designation and represents a call against AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 20, 2026, for Ibrance 100 mg tablets with a ceiling value of $8,559.84 under a firm fixed-price structure.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion by March 13, 2026. No set-aside was used in the award.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $8,559.84 for Ibrance 100 mg capsule 21-count units.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 3, 2026. Pricing is firm fixed price. No set-aside was used.</p>
- SPE2DR25D3020Indefinite Delivery Contract
- SPE2DR25D3020-SPE2DR26F9S2PDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for Ibrance 125 mg tablets (7-count packages) with a ceiling value of $8,555.21. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 16, 2026. This delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical supply support to military healthcare programs globally.
Generated 5/24/26, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 2/22/26 |